Logo
I

Iveric Bio, An Astellas Company

100 employees

Iveric Bio is now part of Astellas. Follow Astellas Pharma as we continue advancing therapies in ophthalmology. The Iveric Bio page is no longer active or monitored. ​ Show more Show less

Investor insights

Funding rounds participated in

$300M sweet spot round size

Investor type

Public Company

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Funding rounds raised

Total raised

$300M

from investors over 1 rounds

I

Iveric Bio, An Astellas Company raised $300M on December 30, 2022

FAQ